We therefore next investigated whether or not K‐563 inhibited the Keap1/Nrf2 downstream gene expression and exerted cell growth inhibition in other Keap1‐ or Nrf2‐mutated human cancer cell lines. The gene discussed is NFE2L2; the disease is cancer.